Literature DB >> 28168553

CCR2 contributes to the recruitment of monocytes and leads to kidney inflammation and fibrosis development.

Tarcio Teodoro Braga1, Matheus Correa-Costa2, Reinaldo Correia Silva2, Mario Costa Cruz2, Meire Ioshie Hiyane2, Joao Santana da Silva3, Katia Regina Perez4, Iolanda Midea Cuccovia4, Niels Olsen Saraiva Camara2,5,6.   

Abstract

Chemokines are a large family of proteins that, once associated to its receptor on leukocytes, stimulate their movement and migration from blood to tissues. Once in the tissue, immune cells trigger inflammation that, when uncontrolled, leads to fibrosis development. Among the immune cells, macrophages take a special role in fibrosis formation, since macrophage depletion reflects less collagen deposition. The majority of tissue macrophages is derived from monocytes, especially monocytes expressing the chemokine receptor CCR2. Here, we investigated the role of infiltrating CCR2+ cells in the development of fibrosis, and specifically, the dynamic of infiltration of these cells into kidneys under chronic obstructive lesion. Using liposome-encapsulated clodronate, we observed that macrophage depletion culminated in less collagen deposition and reduced chemokines milieu that were released in the damaged kidney after obstructive nephropathy. We also obstructed the kidneys of CCL3-/-, CCR2-/-, CCR4-/-, CCR5-/-, and C57BL/6 mice and we found that among all animals, CCR2-/- mice demonstrated the more robust protection, reflected by less inflammatory and Th17-related cytokines and less collagen formation. Next we evaluated the dynamic of CCR2+/rfp cell infiltration and we observed that they adhere onto the vessels at early stages of disease, culminating in increased recruitment of CCR2+/rfp cells at later stages. On the other hand, CCR2rfp/rfp animals exhibited less fibrosis formation and reduced numbers of recruited cells at later stages. We have experimentally demonstrated that inflammatory CCR2+ cells that reach the injured kidney at initial stages after tissue damage are responsible for the fibrotic pattern observed at later time points in the context of UUO.

Entities:  

Keywords:  CCR2+ monocytes; Fibrosis; UUO

Mesh:

Substances:

Year:  2017        PMID: 28168553     DOI: 10.1007/s10787-017-0317-4

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  56 in total

1.  MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages.

Authors:  Tarcio Teodoro Braga; Matheus Correa-Costa; Yuri Felipe Souza Guise; Angela Castoldi; Cassiano Donizetti de Oliveira; Meire Ioshie Hyane; Marcos Antonio Cenedeze; Simone Aparecida Teixeira; Marcelo Nicolas Muscara; Katia Regina Perez; Iolanda Midea Cuccovia; Alvaro Pacheco-Silva; Giselle Martins Gonçalves; Niels Olsen Saraiva Camara
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

2.  Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression.

Authors:  Su-Mi Kim; Sang-Ho Lee; Arah Lee; Dong-Jin Kim; Yang-Gyun Kim; Se-Yun Kim; Kyung-Hwan Jeong; Tae-Won Lee; Chun-Gyoo Ihm; Sung-Jig Lim; Ju-Young Moon
Journal:  Transl Res       Date:  2015-05-05       Impact factor: 7.012

Review 3.  Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.

Authors:  Stephan Segerer; Peter J Nelson; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

4.  CCR2 polymorphism in chronic renal failure patients requiring long-term hemodialysis.

Authors:  Ilhan Sezgin; Binnur Koksal; Gokhan Bagci; Hande Kucuk Kurtulgan; Ozturk Ozdemir
Journal:  Intern Med       Date:  2011-11-01       Impact factor: 1.271

5.  CCR2 signaling contributes to ischemia-reperfusion injury in kidney.

Authors:  Kengo Furuichi; Takashi Wada; Yasunori Iwata; Kiyoki Kitagawa; Ken-Ichi Kobayashi; Hiroyuki Hashimoto; Yoshiro Ishiwata; Masahide Asano; Hui Wang; Kouji Matsushima; Motohiro Takeya; William A Kuziel; Naofumi Mukaida; Hitoshi Yokoyama
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

6.  CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis.

Authors:  Xiaogang Peng; Jing Zhang; Zhicheng Xiao; Yanjun Dong; Jie Du
Journal:  J Immunol       Date:  2015-08-07       Impact factor: 5.422

7.  A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis.

Authors:  Glenda Trujillo; Erica C O'Connor; Steven L Kunkel; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

8.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

9.  Blockade of CCR2 ameliorates progressive fibrosis in kidney.

Authors:  Kiyoki Kitagawa; Takashi Wada; Kengo Furuichi; Hiroyuki Hashimoto; Yoshiro Ishiwata; Masahide Asano; Motohiro Takeya; William A Kuziel; Kouji Matsushima; Naofumi Mukaida; Hitoshi Yokoyama
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

10.  Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium.

Authors:  Stefan Porubsky; Holger Schmid; Mahnaz Bonrouhi; Matthias Kretzler; Ernst Malle; Peter J Nelson; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

View more
  16 in total

Review 1.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

2.  F4/80hi Resident Macrophages Contribute to Cisplatin-Induced Renal Fibrosis.

Authors:  Sophia M Sears; Alexis A Vega; Zimple Kurlawala; Gabrielle B Oropilla; Austin Krueger; Parag P Shah; Mark A Doll; Robert Miller; Levi J Beverly; Leah J Siskind
Journal:  Kidney360       Date:  2022-02-10

3.  Transcriptional profile changes after treatment of ischemia reperfusion injury-induced kidney fibrosis with 18β-glycyrrhetinic acid.

Authors:  Yamei Jiang; Chengzhe Cai; Pingbao Zhang; Yongsheng Luo; Jingjing Guo; Jiawei Li; Ruiming Rong; Yi Zhang; Tongyu Zhu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

4.  Opposing actions of renal tubular- and myeloid-derived porcupine in obstruction-induced kidney fibrosis.

Authors:  Xiaohan Lu; Nathan P Rudemiller; Jiafa Ren; Yi Wen; Bo Yang; Robert Griffiths; Jamie R Privratsky; Babita Madan; David M Virshup; Steven D Crowley
Journal:  Kidney Int       Date:  2019-07-31       Impact factor: 10.612

5.  Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2.

Authors:  Michael G Yang; Zili Xiao; Rulin Zhao; Andrew J Tebben; Bei Wang; Robert J Cherney; Douglas G Batt; Gregory D Brown; Mary Ellen Cvijic; John V Duncia; Michael A Gallela; Daniel S Gardner; Purnima Khandelwal; Mary F Malley; Jian Pang; Anne V Rose; Joseph B Santella; Amy A Sarjeant; Songmei Xu; Arvind Mathur; Sandhya Mandlekar; Ragini Vuppugalla; Qihong Zhao; Percy H Carter
Journal:  ACS Med Chem Lett       Date:  2021-05-25       Impact factor: 4.632

6.  Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study.

Authors:  Katrin G Schmidt; Martina Herrero San Juan; Sandra Trautmann; Lucija Berninger; Anja Schwiebs; Florian M Ottenlinger; Dominique Thomas; Frank Zaucke; Josef M Pfeilschifter; Heinfried H Radeke
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

Review 7.  Inflammation in Renal Diseases: New and Old Players.

Authors:  Vinicius Andrade-Oliveira; Orestes Foresto-Neto; Ingrid Kazue Mizuno Watanabe; Roberto Zatz; Niels Olsen Saraiva Câmara
Journal:  Front Pharmacol       Date:  2019-10-08       Impact factor: 5.810

8.  Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity.

Authors:  Ranferi Ocaña-Guzmán; Norma A Téllez-Navarrete; Lucero A Ramón-Luing; Iliana Herrera; Marlon De Ita; José-Luis Carrillo-Alduenda; José Alberto Choreño-Parra; Karen Medina-Quero; Joaquín Zúñiga; Leslie Chávez-Galán
Journal:  J Immunol Res       Date:  2021-04-21       Impact factor: 4.818

9.  Ongoing Exposure to Peritoneal Dialysis Fluid Alters Resident Peritoneal Macrophage Phenotype and Activation Propensity.

Authors:  Tara E Sutherland; Tovah N Shaw; Rachel Lennon; Sarah E Herrick; Dominik Rückerl
Journal:  Front Immunol       Date:  2021-07-27       Impact factor: 7.561

10.  A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.

Authors:  Yi Ding; Tian Li; Min Li; Tuersong Tayier; MeiLin Zhang; Long Chen; ShuMei Feng
Journal:  Biomed Res Int       Date:  2021-06-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.